These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4341570)

  • 1. A new, long-lasting competitive inhibitor of angiotensin.
    Türker RK; Hall MM; Yamamoto M; Sweet CS; Bumpus FM
    Science; 1972 Sep; 177(4055):1203-5. PubMed ID: 4341570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
    Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
    J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of two structurally related analogs of Asp1-Ile5-angiotensin II.
    Türker RK; Gündoğan NU
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(4):411-20. PubMed ID: 4367918
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
    Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract]   [Full Text] [Related]  

  • 5. Change of activity in rabbit aorta of three analogs of angiotensin substituted in nh2-terminal position.
    Türker RK; Ercan ZS
    Pharmacology; 1975; 13(2):155-62. PubMed ID: 1144515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin analogs: the influence of sarcosine substituted in position 1.
    Hall MM; Khosla MC; Khairallah PA; Bumpus FM
    J Pharmacol Exp Ther; 1974 Jan; 188(1):222-8. PubMed ID: 4358436
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of analogs of (8-isoleucine)angiotensin II with variations in position 1.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Apr; 17(4):431-3. PubMed ID: 4364509
    [No Abstract]   [Full Text] [Related]  

  • 8. A potent competitive antagonist of angiotensin II.
    Yamamoto M; Türker RK; Khairallah PA; Bumpus FM
    Eur J Pharmacol; 1972 May; 18(3):316-22. PubMed ID: 4338477
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo studies of (1-sarcosine, 8-threonine) angiotensin II.
    Muñoz-Ramírez H; Khosla MC; Hall MM; Bumpus FM; Khairallah PA
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):649-63. PubMed ID: 4864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II.
    O'Connor GJ; Baranowski RL; Kurtzman NA
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):75-9. PubMed ID: 4370454
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II.
    Khosla MC; Hall MM; Munoz-Ramírez H; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of induced aldosterone biosynthesis with a specific antagonist of angiotensin II.
    Chiu AT; Peach MJ
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):341-4. PubMed ID: 4360940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase synthesis of (6-arginine)-, (4-histidine, 6-tyrosine)-, and (8-isoleucine)angiotensins II.
    Khosla MC; Kumar S; Smeby RR; Bumpus FM
    J Med Chem; 1972 Jun; 15(6):627-9. PubMed ID: 4337901
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative pharmacology of new specific angiotensin antagonists.
    Schoelkens BA
    Clin Sci Mol Med Suppl; 1975 Jun; 2():19s-21s. PubMed ID: 1077769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of central hypertensive activity of angiotensin I and II by 1-sar-8-ala-angiotensin II (saralasin acetate).
    Solomon TA; Buckley JP
    J Pharm Sci; 1974 Jul; 63(7):1109-13. PubMed ID: 4368826
    [No Abstract]   [Full Text] [Related]  

  • 16. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767
    [No Abstract]   [Full Text] [Related]  

  • 17. Amino acid side chain conformation in angiotensin II and analogs: correlated results of circular dichroism and 1H nuclear magnetic resonance.
    Piriou F; Lintner K; Fermandjian S; Fromageot P; Khosla MC; Smeby RR; Bumpus FM
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):82-6. PubMed ID: 6928653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I.
    Paiva AC; Nouaihetas VL; Miyamoto ME; Mendes GB; Paiva TB
    J Med Chem; 1973 Jan; 16(1):6-9. PubMed ID: 4344926
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Antagonism of central dipsogenic and peripheral vasoconstrictor reponses to angiotensin II with Sar Ala8 angiotensin II in the conscious cat.
    Cooling MJ; Day MD
    J Pharm Pharmacol; 1973 Dec; 25(12):1005-6. PubMed ID: 4150284
    [No Abstract]   [Full Text] [Related]  

  • 20. 1,8-disubstituted analogues of (Ile5) and (Val5)angiotensin II: difference in potency and specificity of angiotensin II-antagonistic activity.
    Schoelkens BA; Wissmann H; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):825-38. PubMed ID: 955577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.